SALBUTAMOL AND IPRATROPIUM BROMIDE ARE HIGH RISK FACTORS FOR ATRIAL ARRHYTHMIAS IN PATIENTS WITH COPD AND CVS DISEASES.

R. Sethi (YEREVAN, Armenia), H. Zakharyan (YEREVAN, Armenia), A. Muradyan (YEREVAN, Armenia)

Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Session: COPD treatment: cardiovascular, oxygen and vaccination studies
Session type: Thematic Poster
Number: 2462
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Sethi (YEREVAN, Armenia), H. Zakharyan (YEREVAN, Armenia), A. Muradyan (YEREVAN, Armenia). SALBUTAMOL AND IPRATROPIUM BROMIDE ARE HIGH RISK FACTORS FOR ATRIAL ARRHYTHMIAS IN PATIENTS WITH COPD AND CVS DISEASES.. 2462

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
UTILITY OF THE HIGH FLOW WITH NASAL CANNULA IN THE DECANULATION OF TRAQUEOTOMIZED PATIENTS DURING AN EPISODE OF ACUTE RESPIRATORY INSUFFICIENCY.
Source: International Congress 2018 – New tools for managing respiratory failure
Year: 2018

INCIDENCE AND RISK FACTORS FOR NEW ATRIAL ARRHYTMIA IN PNEUMOCOCCAL PNEUMONIA
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018


DIFFERENCES OF ANXIETY, DEPRESSION AND FUNCTIONAL CAPACITY BETWEEN PATIENTS WITH CARDIORESPIRATORY FAILURE WITH PARTIAL AND TOTAL  ADHERENCE
Source: Virtual Congress 2020 – Pulmonary function and rehabilitation in non-respiratory disease
Year: 2020


NEBULIZER AEROSOL DRUG DELIVERY THROUGH HIGH FLOW NASAL CANNULA IN ADULT PATIENTS
Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Year: 2020


GLN27GLU POLYMORPHISM IN THE ß2-ADRENERGIC RECEPTOR GENE AND THE RISK OF ARTERIAL HYPERTENSION IN PATIENTS WITH BRONCHIAL ASTHMA
Source: International Congress 2018 – Physiological and biological insights in asthma
Year: 2018


RISK FACTORS FOR LONG-TERM MORTALITY IN PATIENTS WITH PNEUMOCOCCAL COMMUNITY-ACQUIRED PNEUMONIA
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018


HEART VARIABILITY IN THE PRESENCE OF PSYCHOLOGICAL STRESS AND QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care
Year: 2020

INSPIRATORY MUSCLE TRAINING BASED ON THE ANAEROBIOSIS THRESHOLD ON THE FUNCTIONAL CAPACITY OF PATIENTS SUBMITTED TO CORONARY ARTERIAL BYPASS GRAFTING: RANDOMIZED AND CONTROLLED CLINICAL TRIAL
Source: International Congress 2019 – Cardiopulmonary exercise testing
Year: 2019


PULMONARY REHABILITATION EFFECT ON SYSTEMIC INFLAMMATION VALUES, APOB48, LIPIDEMIA AND CARDIOVASCULAR RISK IN PATIENTS WITH COPD
Source: International Congress 2019 – Pulmonary rehabilitation for obstructive lung diseases
Year: 2019


DIFFERENCES IN PSYCHOLOGICAL FACTORS BETWEEN PATIENTS WITH LEFT HEART FAILURE AND RIGHT HEART FAILURE ASSOCIATED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Source: Virtual Congress 2020 – Pulmonary embolism and beyond
Year: 2020

OBSTACLE OF PHYSICAL ACTIVITY AND ACTIVITIES OF DAILY LIVING IN PATIENTS WITH COPD: DYSPNEA RELATED KINESIOPHOBIA
Source: International Congress 2019 – Breathing, posture and physical activity in respiratory disease patients
Year: 2019


PHYSIOLOGICAL EFFECTS OF THREE DIFFERENT VENTILATORY MODES IN PATIENTS WITH OBESITY HYPOVENTILATION SYNDROME UNDER NOCTURNAL NONINVASIVE VENTILATION: A PILOT RANDOMIZED STUDY
Source: International Congress 2017 – Noninvasive ventilation for chronic respiratory failure
Year: 2017

FUNCTIONAL AND METABOLIC CHARACTERISTICS OF BRONCHOALVEOLAR LAVAGE FLUID CELLS IN PATIENTS WITH PROLONGED COMMUNITY ACQUIRED PNEUMONIA
Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases
Year: 2021


SERUM OSMOLARITY IS ASSOCIATED WITH SEVERITY OF OBSTRUCTIVE SLEEP APNEA SYNDROME: A NOVEL RISK FACTOR FOR CARDIOVASCULAR DISEASE
Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities
Year: 2018

ASSOCIATION OF EXERCISE CAPACITY AND ENDOTHELIAL FUNCTION IN PATIENTS WITH FIBROSING INTERSTITIAL LUNG DISEASE
Source: Virtual Congress 2021 – Peripheral muscle function, exercise capacity and functional status in respiratory disease
Year: 2021


ORAL MORPHINE IS SAFE IN SYMPTOMATIC PATIENTS WITH FIBROTIC INTERSTITIAL LUNG DISEASES
Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia
Year: 2019

EARLY DIAGNOSIS OF LUNG VENTILATION EVENNESS DISORDERS USING NONINVASIVE IMAGING
Source: Virtual Congress 2021 – Pulmonary neoplasia and related pathologies
Year: 2021

VENTILATORY MUSCLE STRENGTH SIX MONTHS AFTER CORONARY ARTERY BYPASS GRAFTING IN PATIENTS SUBMITTED TO INSPIRATORY MUSCULAR TRAINING BASED ON THE ANAEROBIOSIS THRESHOLD: CLINICAL TRIAL
Source: Virtual Congress 2021 – An update on respiratory physiotherapy and respiratory muscle function and training
Year: 2021


FACTORS INFLUENCING PHARMACOLOGICAL TREATMENT IN COPD PATIENTS  ENROLED IN AN INTEGRATED DISEASE MANAGEMENT PROGRAMME (IDMP)
Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet?
Year: 2018




IMMUNOLOGICAL EVENTS AND SURVIVAL IN LUNG CANCER PATIENTS WITH COPD
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020